Cardinal Health is building its drug distribution portfolio with the acquisition of Kinray, Inc., a Whitestone, N.Y.-based privately held distributor of branded and generic medicines to more than ...
DUBLIN, Ohio — Say goodbye to Kinray, the service-obsessed regional drug wholesaler. But say hello to a more muscular and diversified Cardinal Health. The wholesale and health services giant announced ...
Cardinal Health Inc., a $99 billion health care services company, announced its acquisition of drug distributor Kinray Inc. for $1.3 billion in cash to expand its presence in community pharmacy. The ...
DUBLIN, Ohio, Nov. 18, 2010 /PRNewswire-FirstCall/ -- Cardinal Health (NYSE: CAH) today announced plans to acquire Kinray, Inc., a leading pharmaceutical distributor ...
Cardinal Health Inc. (NYSE:CAH) has received federal regulatory clearance to move ahead with its $1.3 billion purchase of New York-area drug distributor Kinray Inc. Cardinal expects to close the deal ...
DUBLIN, Ohio Cardinal Health is looking to expand the pharmaceutical segment of its business by acquiring a pharmaceutical distributor serving the New York metropolitan area. The company said its ...
With an eye toward expanding its access to independent pharmacies in the northeast, Cardinal Health says it will acquire Kinray, Inc., a pharmaceutical distributor serving the New York City area, in ...
Cardinal Health Inc., the Dublin, Ohio-based drug distributor, said it plans to buy closely held Kinray Inc. for $1.3 billion to expand in retail pharmacy distribution. The deal may enhance earnings ...
NEW YORK (Reuters) - Drug wholesaler Cardinal Health Inc plans to buy privately held pharmaceutical distributor Kinray Inc for $1.3 billion to boost its presence in the northeastern United States.
Drug wholesaler Cardinal Health Inc. said it plans to buy privately held pharmaceutical distributor Kinray Inc. for $1.3 billion, a deal that would boost Cardinal's presence in smaller pharmacies in ...
NEW YORK, Nov 18 (Reuters) - Drug wholesaler Cardinal Health Inc plans to buy privately held pharmaceutical distributor Kinray Inc for $1.3 billion to boost its presence in the U.S. Northeast and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results